Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

被引:63
作者
Leung, Christopher [1 ,2 ]
Herath, Chandana B. [1 ]
Jia, Zhiyuan [1 ]
Andrikopoulos, Sof [1 ]
Brown, Bronwyn E. [3 ]
Davies, Michael J. [3 ]
Rivera, Leni R. [4 ,5 ]
Furness, John B. [4 ]
Forbes, Josephine M. [6 ]
Angus, Peter W. [1 ,2 ]
机构
[1] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic 3084, Australia
[2] Austin Hosp, Austin Hlth, Dept Gastroenterol & Hepatol, Melbourne, Vic 3084, Australia
[3] Heart Res Inst, Newtown, NSW 2042, Australia
[4] Univ Melbourne, Parkville, Vic 3052, Australia
[5] Deakin Univ, Metab Res Unit, Sch Med, Geelong, Vic 3216, Australia
[6] Mater Med Res Inst, Glycat & Diabet Complicat Grp, South Brisbane, Qld 4101, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Advanced glycation end-products; Fructose; Steatohepatitis; Non-alcoholic fatty liver disease; Hepatic fibrosis; Oxidative stress; HEPATIC STELLATE CELLS; NADPH OXIDASE; OXIDATIVE STRESS; ANIMAL-MODELS; RECEPTOR; FIBROSIS; MICE; STEATOHEPATITIS; PROGRESSION; ENDPRODUCTS;
D O I
10.3748/wjg.v22.i35.8026
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To determine if manipulation of dietary advanced glycation end product (AGE), intake affects nonalcoholic fatty liver disease (NAFLD) progression and whether these effects are mediated via RAGE. METHODS Male C57Bl6 mice were fed a high fat, high fructose, high cholesterol (HFHC) diet for 33 wk and compared with animals on normal chow. A third group were given a HFHC diet that was high in AGEs. Another group was given a HFHC diet that was marinated in vinegar to prevent the formation of AGEs. In a second experiment, RAGE KO animals were fed a HFHC diet or a high AGE HFHC diet and compared with wildtype controls. Hepatic biochemistry, histology, picrosirius red morphometry and hepatic mRNA were determined. RESULTS Long-term consumption of the HFHC diet generated significant steatohepatitis and fibrosis after 33 wk. In this model, hepatic 4-hydroxynonenal content (a marker of chronic oxidative stress), hepatocyte ballooning, picrosirius red staining, alpha-smooth muscle actin and collagen type 1A gene expression were all significantly increased. Increasing the AGE content of the HFHC diet by baking further increased these markers of liver damage, but this was abrogated by pre-marination in acetic acid. In response to the HFHC diet, RAGE(-/-) animals developed NASH of similar severity to RAGE(+/+) animals but were protected from the additional harmful effects of the high AGE containing diet. Studies in isolated Kupffer cells showed that AGEs increase cell proliferation and oxidative stress, providing a likely mechanism through which these compounds contribute to liver injury. CONCLUSION In the HFHC model of NAFLD, manipulation of dietary AGEs modulates liver injury, inflammation, and liver fibrosis via a RAGE dependent pathway. This suggests that pharmacological and dietary strategies targeting the AGE/RAGE pathway could slow the progression of NAFLD.
引用
收藏
页码:8026 / 8040
页数:15
相关论文
共 50 条
[41]   Non-alcoholic fatty liver disease [J].
Sattar, Naveed ;
Forrest, Ewan ;
Preiss, David .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[42]   Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease [J].
Tan, Panli ;
Jin, Li ;
Qin, Xiang ;
He, Beihui .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[43]   Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance [J].
Zeng, Qingmin ;
Liu, Chang-Hai ;
Ampuero, Javier ;
Wu, Dongbo ;
Jiang, Wei ;
Zhou, Lingyun ;
Li, Hong ;
Bai, Lang ;
Romero-Gomez, Manuel ;
Tang, Hong .
RNA BIOLOGY, 2024, 21 (01) :1-15
[44]   Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring [J].
Long, Michelle T. ;
Gurary, Ellen B. ;
Massaro, Joseph M. ;
Ma, Jiantao ;
Hoffmann, Udo ;
Chung, Raymond T. ;
Benjamin, Emelia J. ;
Loomba, Rohit .
LIVER INTERNATIONAL, 2019, 39 (04) :740-747
[45]   N-Acetylcysteine Improves Liver Function in Patients with Non-Alcoholic Fatty Liver Disease [J].
Khoshbaten, Manouchehr ;
Aliasgarzadeh, Akbar ;
Masnadi, Koorosh ;
Tarzamani, Mohammad K. ;
Farhang, Sara ;
Babaei, Hosain ;
Kiani, Javad ;
Zaare, Maryam ;
Najafipoor, Farzad .
HEPATITIS MONTHLY, 2010, 10 (01) :12-16
[46]   Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease [J].
Zhang, Yali ;
Wu, Beibei ;
Zhang, Hailing ;
Ge, Xiangting ;
Ying, Shilong ;
Hu, Mengwei ;
Li, Weixin ;
Huang, Yi ;
Wang, Li ;
Chen, Chao ;
Shan, Xiaoou ;
Liang, Guang .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (02) :936-947
[47]   The Natural History of Non-Alcoholic Fatty Liver Disease [J].
Caldwell, Stephen ;
Argo, Curtis .
DIGESTIVE DISEASES, 2010, 28 (01) :162-168
[48]   Natural history of non-alcoholic fatty liver disease [J].
Pais, R. .
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2022, 26 (03) :88-92
[49]   Non-alcoholic fatty liver disease: Definition and subtypes [J].
Han, Seul Ki ;
Baik, Soon Koo ;
Kim, Moon Young .
CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 :S5-S16
[50]   Current treatment of non-alcoholic fatty liver disease [J].
Paternostro, Rafael ;
Trauner, Michael .
JOURNAL OF INTERNAL MEDICINE, 2022, 292 (02) :190-204